CPRX Catalyst Pharmaceuticals PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: CPRX
- PE Ratio
The current P/E ratio for Catalyst Pharmaceuticals stock as of Jun 25, 2025 is 13.05. This is calculated based on the current EPS of $1.65 and the stock price of $21.54 per share. The PE ratio has decreased by 27% from the past four quarters average of 18.0.
CPRX PE ratio history
The average historical PE ratio of Catalyst Pharmaceuticals for the last six years is 17.16. The current price-to-earnings ratio of 13.05 is 24% less than the historical average. In the past six years, CPRX's PE ratio reached its highest point in the Sep 2019 quarter at 59, when the stock price was $5.31 and the EPS was $0.09. The lowest point was recorded in the Sep 2020 quarter, when it reached 4.3 with a price of $2.97 and an EPS of $0.69.
Catalyst Pharmaceuticals PE ratio by year
Maximum annual increase: 284.05% in 2021
Maximum annual decrease: -61.65% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 15.12 | -39.74% | $20.87 | $1.38 |
| 2023 | 25.09 | 7.91% | $16.81 | $0.67 |
| 2022 | 23.25 | 30.47% | $18.6 | $0.8 |
| 2021 | 17.82 | 284.05% | $6.77 | $0.38 |
| 2020 | 4.64 | -61.65% | $3.34 | $0.72 |
| 2019 | 12.1 | N/A | $3.75 | $0.31 |
| 2018 | N/A | N/A | $1.92 | -$0.33 |
| 2017 | N/A | N/A | $3.91 | -$0.21 |
| 2016 | N/A | N/A | $1.05 | -$0.22 |
| 2015 | N/A | N/A | $2.45 | -$0.25 |
| 2014 | N/A | N/A | $2.97 | -$0.24 |
| 2013 | N/A | N/A | $1.95 | -$0.27 |
| 2012 | N/A | N/A | $0.44 | -$0.14 |
| 2011 | N/A | N/A | $1.29 | -$0.29 |
| 2010 | N/A | N/A | $0.99 | -$0.22 |
Catalyst Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 14.7 | -2.78% | $24.25 | $1.65 |
| Dec 2024 | 15.12 | -4.91% | $20.87 | $1.38 |
| Sep 2024 | 15.9 | -39.43% | $19.88 | $1.25 |
| Jun 2024 | 26.25 | -1.2% | $15.49 | $0.59 |
| Mar 2024 | 26.57 | 5.9% | $15.94 | $0.6 |
| Dec 2023 | 25.09 | 26.65% | $16.81 | $0.67 |
| Sep 2023 | 19.81 | 62.11% | $11.69 | $0.59 |
| Jun 2023 | 12.22 | -29.97% | $13.44 | $1.1 |
| Mar 2023 | 17.45 | -24.95% | $16.58 | $0.95 |
| Dec 2022 | 23.25 | 17.78% | $18.6 | $0.8 |
| Sep 2022 | 19.74 | 49.21% | $12.83 | $0.65 |
| Jun 2022 | 13.23 | -29.78% | $7.01 | $0.53 |
| Mar 2022 | 18.84 | 5.72% | $8.29 | $0.44 |
| Dec 2021 | 17.82 | 34.49% | $6.77 | $0.38 |
| Sep 2021 | 13.25 | 65.83% | $5.3 | $0.4 |
CPRX Price vs fair value
CPRX average PE ratio chart
The current PE ratio of CPRX is lower than the 3, 5 and 10-year averages.
CPRX PE vs peers
When compared to its peer stocks JNJ and ABT, CPRX's PE ratio is lower. Catalyst Pharmaceuticals is presently trading at a lower PE ratio (13.05) than its peer group average of 17.94.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CPRX Catalyst Pharmaceuticals Inc | 13.05 | $2.63B |
| JNJ Johnson & Johnson | 16.81 | $366.4B |
| PFE Pfizer Inc | 17.45 | $137.93B |
| ABT Abbott Laboratories | 17.8 | $239.05B |
| BMRN Biomarin Pharmaceutical Inc | 19.69 | $10.38B |
| SRPT Sarepta Therapeutics Inc | N/A | $1.72B |
Frequently asked questions
What is Catalyst Pharmaceuticals's PE ratio?
CPRX stock has a price to earnings ratio of 13.05 as of Jun 25, 2025.
What is the 3-year average PE ratio for Catalyst Pharmaceuticals (CPRX)?
As an average over the last 3 years, CPRX stock has a PE ratio of 19.11.
What is the 5-year average PE ratio for Catalyst Pharmaceuticals (CPRX)?
As an average over the last 5 years, CPRX stock has a PE ratio of 15.72.
What is the highest PE ratio for CPRX?
Over the last six years, the quarterly PE ratio reached a historic high of 59 in the Sep 2019 quarter.
How does the current PE ratio for CPRX compare to its historical average?
The current price to earnings ratio of CPRX is 24% lower than the 6-year historical average.
How is CPRX's PE ratio calculated (Catalyst Pharmaceuticals PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jun 25, 2025), Catalyst Pharmaceuticals's stock price is $21.54. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $1.65. Therefore, Catalyst Pharmaceuticals's price to earnings ratio for today is 13.05. PE RATIO(13.05) = STOCK PRICE($21.54) / TTM EPS($1.65)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.